Mirena Observational Program

CompletedOBSERVATIONAL
Enrollment

2,725

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

April 30, 2014

Study Completion Date

November 30, 2015

Conditions
ContraceptionMenorrhagiaEndometrial HyperplasiaEstrogen Replacement Therapy
Interventions
DRUG

Levonorgestrel (Mirena, BAY86-5028)

Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00883662 - Mirena Observational Program | Biotech Hunter | Biotech Hunter